Aminolevulinic acid (ALA)–protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies
暂无分享,去创建一个
[1] Keith D. Paulsen,et al. Estimation of Brain Deformation for Volumetric Image Updating in Protoporphyrin IX Fluorescence-Guided Resection , 2009, Stereotactic and Functional Neurosurgery.
[2] Jörg-Christian Tonn,et al. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article. , 2011, Journal of neurosurgery.
[3] Kaoru Sakatani,et al. Quantitative spectroscopic analysis of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence intensity in diffusely infiltrating astrocytomas. , 2007, Neurologia medico-chirurgica.
[4] F. Floeth,et al. Finding the anaplastic focus in diffuse gliomas: The value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence , 2011, Clinical Neurology and Neurosurgery.
[5] Z L Gokaslan,et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.
[6] J. Felsberg,et al. Fluorescence-Guided Resection of Spinal Metastases of Malignant Glioma: Report of 2 Cases , 2011, Journal of Neurological Surgery—Part A.
[7] J. Fandino,et al. Intraoperative 5-aminolevulinic-acid-induced fluorescence in meningiomas , 2010, Acta Neurochirurgica.
[8] Y. Kajimoto,et al. Use of 5-aminolevulinic acid in fluorescence-guided resection of meningioma with high risk of recurrence. Case report. , 2007, Journal of neurosurgery.
[9] S. Goldman,et al. POSITRON EMISSION TOMOGRAPHY‐GUIDED VOLUMETRIC RESECTION OF SUPRATENTORIAL HIGH‐GRADE GLIOMAS: A SURVIVAL ANALYSIS IN 66 CONSECUTIVE PATIENTS , 2009, Neurosurgery.
[10] Arya Nabavi,et al. High-field iMRI in glioblastoma surgery: improvement of resection radicality and survival for the patient? , 2011, Acta neurochirurgica. Supplement.
[11] W. Stummer,et al. Technical Principles for Protoporphyrin-IX-Fluorescence Guided Microsurgical Resection of Malignant Glioma Tissue , 1998, Acta Neurochirurgica.
[12] S. Tejada Solis,et al. Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience , 2011, Journal of Neuro-Oncology.
[13] Ricardo J Komotar,et al. Neurosurgery for Brain Tumors: Update on Recent Technical Advances , 2011, Current neurology and neuroscience reports.
[14] W. Curran,et al. Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. , 1998, International journal of radiation oncology, biology, physics.
[15] H Stepp,et al. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. , 1998, Neurosurgery.
[16] Paul S Mischel,et al. MR imaging correlates of survival in patients with high-grade gliomas. , 2005, AJNR. American journal of neuroradiology.
[17] Jochen Herms,et al. 5‐Aminolevulinic Acid‐induced Protoporphyrin IX Levels in Tissue of Human Malignant Brain Tumors , 2010, Photochemistry and photobiology.
[18] K. Fujii,et al. Fluorescence diagnosis of tumor cells in hemangioblastoma cysts with 5-aminolevulinic acid. , 2010, Journal of neurosurgery.
[19] M. Berger,et al. The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. , 1999, Surgical neurology.
[20] Sachio Suzuki,et al. Histological examination of false positive tissue resection using 5-aminolevulinic acid-induced fluorescence guidance. , 2007, Neurologia medico-chirurgica.
[21] J. Henson,et al. Brain Tumor Imaging in Clinical Trials , 2008, American Journal of Neuroradiology.
[22] Veit Rohde,et al. EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME: IDENTIFICATION OF AND ADJUSTMENT FOR BIAS , 2008, Neurosurgery.
[23] Gabriele Schackert,et al. Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. , 2008, Neuro-oncology.
[24] S. Eicker,et al. ALA-induced porphyrin accumulation in medulloblastoma and its use for fluorescence-guided surgery. , 2011, Central European neurosurgery.
[25] Y. Kajimoto,et al. FLUORESCENCE OF NON‐NEOPLASTIC, MAGNETIC RESONANCE IMAGING‐ENHANCING TISSUE BY 5‐AMINOLEVULINIC ACID: CASE REPORT , 2007, Neurosurgery.
[26] Volker Seifert,et al. Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. , 2011, The Lancet. Oncology.
[27] K. Franz,et al. Influence of iMRI-Guidance on the Extent of Resection and Survival of Patients with Glioblastoma Multiforme , 2010, Technology in cancer research & treatment.
[28] Christopher Nimsky,et al. Volumetric Assessment of Glioma Removal by Intraoperative High-field Magnetic Resonance Imaging , 2004, Neurosurgery.
[29] Xiaoyao Fan,et al. Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article. , 2011, Journal of neurosurgery.
[30] I. Nagata,et al. USEFULNESS OF INTRAOPERATIVE PHOTODYNAMIC DIAGNOSIS USING 5‐AMINOLEVULINIC ACID FOR MENINGIOMAS WITH CRANIAL INVASION: TECHNICAL CASE REPORT , 2008, Neurosurgery.
[31] F. Zanella,et al. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.
[32] R. Alday,et al. Risk Factors Predicting Recurrence in Patients Operated on for Intracranial Meningioma. A Multivariate Analysis , 1999, Acta Neurochirurgica.
[33] Xiaoyao Fan,et al. Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. , 2011, Journal of neurosurgery.
[34] Wei Huang,et al. Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. , 2003, Journal of neurosurgery.
[35] R. Mirimanoff,et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.
[36] Kimito Yamada,et al. Use of 5-aminolevulinic acid for the confirmation of deep-seated brain tumors during stereotactic biopsy. Report of 2 cases. , 2011, Journal of neurosurgery.
[37] H Stepp,et al. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. , 2000, Journal of neurosurgery.
[38] D. Prayer,et al. 5‐Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement , 2010, Cancer.
[39] Keith D. Paulsen,et al. δ-aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancy. , 2011, Neuro-oncology.
[40] G von Campe,et al. 5-aminolevulinic acid induced protoporphyrin IX fluorescence in high-grade glioma surgery: a one-year experience at a single institutuion. , 2008, Swiss medical weekly.
[41] Sachio Suzuki,et al. Fluorescence-guided resection of metastatic brain tumors using a 5-aminolevulinic acid-induced protoporphyrin IX: pathological study , 2007, Brain Tumor Pathology.
[42] A. Koch,et al. Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas , 2009, Acta Neurochirurgica.
[43] M. Idoate,et al. Pathological characterization of the glioblastoma border as shown during surgery using 5‐aminolevulinic acid‐induced fluorescence , 2011, Neuropathology : official journal of the Japanese Society of Neuropathology.
[44] Michael Sabel,et al. Comparison of 18F-FET PET and 5-ALA fluorescence in cerebral gliomas , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[45] Henry Brem,et al. Independent association of extent of resection with survival in patients with malignant brain astrocytoma. , 2009, Journal of neurosurgery.